XML 80 R55.htm IDEA: XBRL DOCUMENT
v3.20.4

SHAREHOLDERS' EQUITY (Details Textual) $ / shares in Units, $ in Thousands |  |  | 1 Months Ended | 12 Months Ended | 36 Months Ended |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 03, 2020 $ / shares shares | Jul. 06, 2020 $ / shares shares | Jun. 12, 2019 $ / shares shares | Jun. 06, 2019 $ / shares shares | Jun. 05, 2019 $ / shares shares | Apr. 30, 2019 $ / shares shares | Mar. 27, 2019 | Feb. 28, 2019 USD ($) $ / shares shares | Nov. 30, 2018 | May 31, 2018 | Mar. 06, 2018 USD ($) shares | Feb. 10, 2021 shares | Dec. 31, 2020 USD ($) $ / shares shares | Dec. 31, 2019 USD ($) $ / shares shares | Dec. 31, 2018 USD ($) $ / shares shares | Dec. 31, 2015 $ / shares | Dec. 31, 2020 USD ($) shares | Dec. 31, 2020 ₪ / shares | Dec. 03, 2020 ₪ / shares shares | Jul. 06, 2020 ₪ / shares shares | Feb. 10, 2020 $ / shares shares | Feb. 10, 2020 ₪ / shares shares | Dec. 31, 2019 ₪ / shares shares | Dec. 28, 2016 USD ($) | May 10, 2016 USD ($)
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reverse share split, description |  |  |  |  |  |  |  | The Company’s shareholders approved (i) a reverse share split within a range of 1:8 to 1:32, to be effective at the ratio and on a date to be determined by the Board of Directors, and (ii) amendments to the Company’s Articles of Association authorizing an increase in the Company’s authorized share capital (and corresponding authorized number of ordinary shares, proportionally adjusting such number for the reverse share split) by up to NIS 17.5 million. Following the shareholder approval, an authorized committee of the Board of Directors of the Company approved a one-for-twenty-five reverse share split of the Company’s ordinary shares, and the Company filed the Third Amended and Restated Articles of Association of the Company with the Registrar of Companies of the State of Israel to effect the reverse share split and to increase the Company’s authorized share capital after the effect of the reverse share split. The reverse share split became effective on April 1, 2019. Additionally, effective at the same time, the total number of ordinary shares the Company is authorized to issue changed from 250,000,000 shares to 60,000,000 shares, the par value per share of the ordinary shares changed to NIS 0.25 and the authorized share capital of the Company changed from NIS 2,500,000 to NIS 15,000,000. All share and per share data included in these consolidated financial statements, for periods before December 31, 2019, give retroactive effect to the reverse stock split. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value of shares | ₪ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ₪ 0.25 |  |  |  |  | ₪ 0.25 |  |
Issuance expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,505 |  |  |  |  |  |  |  |  |  |
Options granted (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,389,555 |  |  |  | 11,389,555 |  |  |  |  |  | 2,522,284 |  |
Expected term of shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 years | 6 years 1 month 9 days | 6 years 1 month 9 days |  |  |  |  |  |  |  |  |  |
Warrant exercised |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,651,537 |  |  |  | $ 1,651,537 |  |  |  |  |  |  |  |
Description of underwriting agreement |  |  |  |  |  |  |  |  |  | The Company entered into an underwriting agreement with H.C. Wainwright & Co., LLC (“H.C. Wainwright”), in connection with the Company’s follow-on public offering of 496,055 units, each consisting of one ordinary share and one common warrant to purchase one ordinary share with an exercise price of $7.5 per warrant. Each unit was sold to the public at a price of $7.50 per unit. On November 18, 2018, H.C. Wainwright exercised in full its option to purchase 231,964 ordinary shares for $7.25 per share and/or common warrants to purchase up to an additional 231,964 ordinary shares for $0.25 per warrant. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of underwriters warrants to purchase |  |  |  |  |  |  |  |  |  | The Company issued and sold 1,050,372 pre-funded units at a price to the public of $7.25 per unit. Each unit containing one pre-funded warrant with an exercise price of $0.25 per share and one warrant to purchase one ordinary share with an exercise price of $7.50 per warrant. The total gross proceeds received from the November 2018 follow-on public offering, before deducting commissions, discounts and expenses, were $13.1 million (including proceeds from the exercise of 90,691 pre-funded warrants at the closing of the offering). As of December 31, 2018, additional pre-funded warrants to purchase an aggregate 562,466 ordinary shares had been exercised, for additional proceeds of $140,617. During the year ended December 31, 2019 additional 288,000 pre-funded warrants and 296,087 warrants to purchase an aggregate 584,087 ordinary shares had been exercised, for additional proceeds of $1.5 million. As compensation for their role in the offering, the Company also issued to the Underwriters warrants to purchase up to 106,680 ordinary shares, which became immediately exercisable starting on November 20, 2018 until November 15, 2023 at $9.375 per share. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total gross proceeds received from the follow-on public offering | [1] |  |  |  |  |  |  |  |  |  |  |  |  | $ 7,041 |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase ordinary shares | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,680 |  |  |  |  |  |  |  |  |  |  |  |
Kreos Capital V [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants grant date |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Dec. 31, 2015 |  |  |  |  |  |  |  |  |
Warrants exercisable, description |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Currently exercisable (in whole or in part) until the earlier of (i) December 30, 2025 or (ii) immediately prior to the consummation of a merger, consolidation, or reorganization of us with or into, or the sale or license of all or substantially all the assets or shares of us to, any other entity or person, other than a wholly-owned subsidiary of us, excluding any transaction in which the Company’s shareholders prior to the transaction will hold more than 50% of the voting and economic rights of the surviving entity after the transaction. |  |  |  |  |  |  |  |  |
Restricted Stock Units (RSUs) [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average grant date fair value, restricted stock units (in USD per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.44 | $ 4.67 | $ 26.75 |  |  |  |  |  |  |  |  |  |
Weighted average grant date fair value, options (in USD per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.98 | $ 15.25 |  |  |  |  |  |  |  |  |  |
Employee Stock Option [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares reserved for future issuance (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 604,320 |  |  |  | 604,320 |  |  |  |  |  | 12,409 |  |
Unrecognized cost of shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,000 |  |  |  | $ 2,000 |  |  |  |  |  |  |  |
Expected term of shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 2 months 12 days |  |  |  |  |  |  |  |  |  |  |  |
Total fair value of shares vested | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 676 | 1,175 | 2,918 |  |  |  |  |  |  |  |  |  |
Private Placement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares (in shares) | shares |  |  |  |  |  |  |  |  | 760,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 959 |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock price per share | $ / shares |  |  |  |  |  |  |  |  | $ 5.75 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total gross proceeds received from the follow-on public offering |  |  |  |  |  |  |  |  | $ 4,370 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of wainwright or its designees warrants to purchase |  |  |  |  |  |  |  |  | The Company also issued to H.C Wainwright and/or its designees warrants to purchase up to 45,600 ordinary shares, which are immediately exercisable starting on February 25, 2019 until February 21, 2024 at $7.1875 per share. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Atm Offering Program [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate offering price |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,000
Stock issuance costs under equity distribution agreement as a percent of gross proceeds |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.00%
Issuance of ordinary shares (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 302,092 |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares in an ATM offering of ordinary shares, gross of issuance expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 15,700 |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares in an ATM offering of ordinary shares, net of issuance expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 14,500 |  |  |  |  |  |  |  |  |  |  |  |
Fixed commission rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.00% |  |  |  |  |  |  |  |  |  |  |  |
Fixed commission amount |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 471 |  |  |  |  |  |  |  |  |  |  |  |
Issuance expenses |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 211 |  |  |  |  |  |  |  |  |  |
Fees and other related expenses |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,200 |  |  |  |  |  |  |  |  |  |  |  |
Common units and pre-funded units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares (in shares) | shares |  |  |  |  |  |  |  |  |  |  |  |  | 5,600,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Par value of shares | ₪ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ₪ 0.25 |  |  |
Warrant to purchase one ordinary share | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,546,828 | 1,546,828 |  |  |
Exercise price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.5625 |  |  |  |
Number of warrants issued | shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 336,000 | 336,000 |  |  |
Common units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.25 |  |  |  |
Pre-funded units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1.249 |  |  |  |
Common units and pre-funded units one [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant exercised |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,831,500 |  |  |  | 1,831,500 |  |  |  |  |  |  |  |
Purchase agreement with certain institutional investors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares (in shares) | shares |  | 5,579,776 | 4,938,278 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued price per share | $ / shares |  | $ 1.4337 | $ 1.8225 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Par value of shares | ₪ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ₪ 0.25 | ₪ 0.25 |  |  |  |  |
Exercise price per share | $ / shares |  | $ 1.34 | $ 1.76 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued | shares |  | 4,184,832 | 2,469,139 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4,184,832 | 2,469,139 |  |  |  |  |
Purchase agreement with certain institutional investors [Member] | Additionally Warrants Issued [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share | $ / shares |  | $ 1.7922 | $ 2.2781 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued | shares |  | 334,787 | 296,297 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 334,787 | 296,297 |  |  |  |  |
Timwell Corporation Limited [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate number of ordinary shares | shares |  |  |  |  |  |  |  |  |  |  |  | 640,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds |  |  |  |  |  |  |  |  |  |  |  | $ 20,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees and other related expenses |  |  |  |  |  |  |  |  |  |  |  | 705 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net aggregate proceeds of after deducting fees and other related expenses |  |  |  |  |  |  |  |  |  |  |  | $ 4,300 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of tranche consisting |  |  |  |  |  |  |  |  |  |  | The Company entered into a fee and release agreement with Canaccord Genuity LLC (“Canaccord Genuity”) requiring the Company to pay to Canaccord Genuity, in connection with a settlement, in addition to certain cash amounts, (i) $125 thousand in ordinary shares of the Company after the First Tranche Closing of the Timwell transaction and (ii) $225 thousand in ordinary shares of the Company after the closing of the Second Tranche of the Timwell transaction (or such lower amount if the Second Tranche Closing is less than $10.0 million). The price per share used for calculation of the number of ordinary shares issued by the Company to Canaccord Genuity is based on the volume weighted average price of the Company’s ordinary shares as reported on the Nasdaq Capital Market for the five consecutive trading days prior to the date of issuance. The Company is also obligated to pay $100 thousand in cash following the closing of the Third Tranche of $5.0 million (or such lower amount if the Third Tranche Closing is less than $5.0 million). Following the First Tranche Closing in May 15, 2018, the Company issued 4,715 ordinary shares to Canaccord Genuity. | The Company entered into an investment agreement with Timwell Corporation Limited, a Hong Kong corporation (“Timwell”), as amended on May 15, 2018 (the “Investment Agreement”), pursuant to which the Company agreed to issue to Timwell, in three different tranches, an aggregate of 640,000 ordinary shares in return for aggregate gross proceeds of $20 million. The closing of each tranche is subject to certain closing conditions. The closing of the first tranche (the “First Tranche Closing”) took place on May 15, 2018, upon which Timwell received 160,000 ordinary shares for an aggregate purchase price of $5,000,000, and Timwell and the Company signed a registration rights agreement in the form attached to the Investment Agreement. The net aggregate proceeds of the First Tranche Closing after deducting fees and other related expenses in the amount of approximately $705 thousands were approximately $4.3 million. The remaining investment is to occur in two tranches, including $10 million for the issuance to Timwell of 320,000 ordinary shares (the “Second Tranche”) and $5 million for the issuance to Timwell of 160,000 ordinary shares (the “Third Tranch”). The closing of the second and third tranches is subject to specified closing conditions, including, with respect to the second tranche, the signing of a license agreement and a supply agreement and the formation of the China JV (the “China JV”) based on the JV Framework Agreement, and, with respect to the third tranche, the successful production of certain ReWalk products by the China JV. The second tranche closing was initially expected to occur by July 1, 2018 and the third tranche closing was initially expected to occur by December 31, 2018 and no later than April 1, 2019. |  |  |  |  |  |  |  |  |  |  |  |  |  |
Kreos Capital [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 7.5 |  |  |  |  |  |  |  |  |
Drawdown amount under loan agreement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 8,000 |
Securities Purchase Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price per share | $ / shares |  |  |  | $ 6.00 |  |  | $ 5.14 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of warrants issued | shares |  |  |  | 416,667 |  |  | 408,457 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable, description |  |  |  | Exercisable from June 12, 2019 until December 12, 2024. | Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024. | Exercisable from June 5, 2019 or June 6, 2019 until June 5, 2024 or June 6, 2024. | Exercisable from April 5, 2019 until October 7, 2024. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares, shares | shares |  |  |  | 833,334 | 1,464,665 | 1,464,665 | 816,914 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price ordinary shares | $ / shares |  |  |  | $ 6.00 | $ 7.50 | $ 7.50 | $ 5.2025 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreements [Member] | Israeli [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price ordinary shares | $ / shares |  |  |  | $ 0.25 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreements [Member] | Warrants To Purchase Ordinary Shares[Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercisable, description |  |  |  | Exercisable from June 12, 2019 until June 10, 2024. | Exercisable from June 5, 2019 until June 5, 2024. | Exercisable from June 5, 2019 until June 5, 2024. | Exercisable from April 5, 2019 until April 3, 2024. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of ordinary shares, shares | shares |  |  |  | 50,000 | 87,880 | 87,880 | 49,015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price ordinary shares | $ / shares |  |  |  | $ 7.50 | $ 9.375 | $ 9.375 | $ 6.503125 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Exchange Program [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shareholders' Equity (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Compensation payment |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0 |  |  |  |  |  |  |  |
[1] | See note 8b.

X
- Definition Aggregate number of ordinary shares. + References No definition available. + Details
Name: | rwlk_AggregateNumberOfOrdinaryShares
Namespace Prefix: | rwlk_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Common Stock, Aggregate Offering Price Authorized Under Equity Distribution Agreement + References No definition available. + Details
Name: | rwlk_CommonStockAggregateOfferingPriceAuthorizedUnderEquityDistributionAgreement
Namespace Prefix: | rwlk_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Stock issuance costs under equity distribution agreement as a percent of gross proceeds. + References No definition available. + Details
Name: | rwlk_CommonStockIssuanceCostsUnderEquityDistributionAgreementAsPercentOfGrossProceeds
Namespace Prefix: | rwlk_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of underwriters warrants to purchase. + References No definition available. + Details
Name: | rwlk_DescriptionOfUnderwritersWarrantsToPurchase
Namespace Prefix: | rwlk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of underwriting agreement. + References No definition available. + Details
Name: | rwlk_DescriptionOfUnderwritingAgreement
Namespace Prefix: | rwlk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of wainwright or its designees warrants to purchase. + References No definition available. + Details
Name: | rwlk_DescriptionOfWainwrightOrItsDesigneesWarrantsToPurchase
Namespace Prefix: | rwlk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of fees and other related expenses. + References No definition available. + Details
Name: | rwlk_FeesAndOtherRelatedExpenses
Namespace Prefix: | rwlk_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fixed commission amount. + References No definition available. + Details
Name: | rwlk_FixedCommissionAmount
Namespace Prefix: | rwlk_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fixed commission rate. + References No definition available. + Details
Name: | rwlk_FixedCommissionRate
Namespace Prefix: | rwlk_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net aggregate proceeds of the first tranche closing after deducting fees and other related expenses in the amount of approximately. + References No definition available. + Details
Name: | rwlk_NetAggregateProceedsOfAfterDeductingFeesAndOtherRelatedExpenses
Namespace Prefix: | rwlk_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Exercise price ordinary shares. + References No definition available. + Details
Name: | rwlk_OrdinarySharesExercisePrice
Namespace Prefix: | rwlk_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | rwlk_ShareholdersEquityTextualAbstract
Namespace Prefix: | rwlk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Issuance of ordinary shares, shares. + References No definition available. + Details
Name: | rwlk_StockIssuedDuringPeriodShareOrdinaryShares
Namespace Prefix: | rwlk_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock Issued During Period, Value, New Issues, Gross + References No definition available. + Details
Name: | rwlk_StockIssuedDuringPeriodValueNewIssuesGross
Namespace Prefix: | rwlk_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Warrants exercisable, description. + References No definition available. + Details
Name: | rwlk_WarrantsExercisableDescrition
Namespace Prefix: | rwlk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants to purchase ordinary shares. + References No definition available. + Details
Name: | rwlk_WarrantsToPurchaseOrdinaryShares
Namespace Prefix: | rwlk_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 25 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653 + Details
Name: | us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Date the warrants or rights are exercisable, in CCYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Costs of sales and operating expenses for the period incurred from transactions with related parties. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227 + Details
Name: | us-gaap_CostsAndExpensesRelatedParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of assets pledged to secure a debt instrument. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823 + Details
Name: | us-gaap_DebtInstrumentCollateralAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow associated with the amount received from the stock plan during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromStockPlans
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Description of measurement difference between recognized amounts and resulting measurement differences for securities loaned. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 55 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=99393222&loc=SL20225997-175313 + Details
Name: | us-gaap_SecuritiesLoanedMeasurementDifferenceDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gross number of share options (or share units) granted during the period. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.2) -URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809 + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of options vested. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. + References No definition available. + Details
Name: | us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | dei_LegalEntityAxis=rwlk_KreosCapitalVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_AtmOfferingProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_PreFundedUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_CommonUnitsAndPreFundedUnits1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=rwlk_PurchaseAgreementWithCertainInstitutionalInvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=rwlk_AdditionallyWarrantsIssuedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_TimwellCorporationLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=rwlk_KreosCapitalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | rwlk_AgreementAxis=rwlk_SecuritiesPurchaseAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | rwlk_TypeofCurrencyAxis=rwlk_IsraeliMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=rwlk_WarrantsToPurchaseOrdinarySharesIssuedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | rwlk_AgreementAxis=rwlk_EquityExchangeProgramMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |